Chimeric - Model CHM 0301 - Natural Killer Cells for Derived Allogeneic Therapies

The next generation CORE-NK platform will integrate additional activation and expansion features to further optimize the cancer-fighting power of the CORE-NK platform cells. Development of the next generation CORE-NK platform will be as a combination therapy for blood cancers